Agendia
Irvine, US · Founded 2003 · 224 employees on LinkedIn · 2 known investors
Find your way into Agendia
350 people in our graph share verified history with the Agendia team — schools, employers, funds. One of them is your warm intro.
Logan Hilleunlockedknows Laura van 't Veer · together at UCSF (overlapped)
×2knows the team · via UCSF
×2knows the team · via University of Amsterdam
knows the team · via Leiden University
×6knows the team · via Massachusetts General Hospital
Agendia develops genomic technology and diagnostic tests for breast cancer patients. The company applies genomic science to improve treatment outcomes and quality of life for cancer patients.
Founders & leadership
Agendia was founded in 2003 by Laura van 't Veer, René Bernards, Prof. Laura van 't Veer, PhD, and Prof. Dr. René Bernards, PhD.
LV
Laura van 't VeerinCo-founderLaura van 't Veer is a molecular biologist and co-founder of Agendia who developed genomic diagnostic approaches for breast cancer treatment. Her research has examined tumor genetic profiling to guide treatment decisions, including leadership of the MINDACT clinical trial and work on the MammaPrint test now incorporated into major clinical guidelines.
RB
René BernardsinCo-founderRené Bernards holds a Ph.D. from the University of Leiden and trained at the Whitehead Institute under Robert Weinberg, studying oncogenes and tumor suppressor genes before holding faculty positions at Massachusetts General Hospital and Utrecht University and senior scientist roles at the Netherlands Cancer Institute. He co-founded Agendia in 2003, a genomics-based diagnostic company that developed the first microarray-based breast cancer diagnostic test, and his research has focused on genome-wide functional genetic screens to identify biomarkers of cancer drug response.
PL
Prof. Laura van 't Veer, PhDChief Research Officer, Co-founder
PD
Prof. Dr. René Bernards, PhDCo-Founder and Scientific Advisor
MR
Mark R. StraleyinCEO
Investors · 2
Founder mafia
3 people who came through Agendia went on to found or lead other companies.
In the news
Frequently asked questions
- What does Agendia do?
- Agendia develops genomic technology and diagnostic tests for breast cancer patients. The company applies genomic science to improve treatment outcomes and quality of life for cancer patients.
- Who founded Agendia?
- Agendia was founded by Laura van 't Veer, René Bernards, Prof. Laura van 't Veer, PhD, Prof. Dr. René Bernards, PhD in 2003.
- Who are Agendia's investors?
- Agendia's investors include Korys, Gilde Healthcare.
- Where is Agendia headquartered?
- Agendia is headquartered in Irvine, US.